Attached files

file filename
EX-32.1 - NEPHROS INCex32-1.htm
EX-31.2 - NEPHROS INCex31-2.htm
EX-31.1 - NEPHROS INCex31-1.htm
EX-10.5 - NEPHROS INCex10-5.htm
EX-10.4 - NEPHROS INCex10-4.htm
EX-10.3 - NEPHROS INCex10-3.htm
EX-10.2 - NEPHROS INCex10-2.htm
EX-10.1 - NEPHROS INCex10-1.htm
10-Q - NEPHROS INCform10-q.htm

 

Exhibit 32.2

 

Certification Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

 

In connection with the Quarterly Report on Form 10-Q of Nephros, Inc. (the “Company”) for the period ended September 30, 2018 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, Andrew Astor, Chief Financial Officer of the Company, certifies that:

 

1. the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
   
2. the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

By: /s/ Andrew Astor  
Name: Andrew Astor  
Title:

Chief Financial Officer

(Principal Financial and Accounting Officer)

 
     
Dated: November 8, 2018